The Journal of Cancer Survivorship: Research and Practice publishes original research on cancer survivors, systematic, scoping, and meta-analytic literature reviews, clinical investigations and policy-related research that can impact the quality of care and quality of life of cancer survivors. The journal publishes peer reviewed papers related to improving the understanding, prevention, and management of multiple areas related to cancer survivorship that can affect quality care, symptom management, function, and well-being.

The number of cancer survivors continue to increase worldwide. This journal considers cancer survivors as individuals who were diagnosed with and treated for cancer (either living with or free of cancer), as well as those who after primary treatment continue to receive prolonged treatment. Studies can include adolescents or adults treated for cancer as children, as well as young adults, adults, or older adults. Research and practice involving all these types of cancer survivors is growing rapidly and dissemination of evidence-based information is essential for improved understanding and care.

Publishes basic research, epidemiological studies, clinical investigations, health services and policy-related research
Publishes systematic, meta-analytic and scoping reviews that adhere to the PRISMA reporting guidelines for systematic reviews/meta-analyses or the PRISMA extension for scoping reviews
Improves understanding of survivorship topics affecting quality of care, health, function, and well-being
Reflects growing interest consistent with increasing prevalence rates and future global impact

Editor in Chief
Michael Feuerstein, Ph.D., MPH
Departments of Medical and Clinical Psychology and Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD
Associate Editors
Krishnan Bhaskaran, Ph.D., London School of Hygiene and Tropical Medicine, United Kingdom
Saskia F.A. Duijts, Ph.D., University Medical Center Groningen, Amsterdam University Medical Center, The Netherlands
Shawna Hudson, Ph.D., UMDNJ- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
Jennifer M. Jones, Ph.D., Toronto General Research Institute, Toronto, Ontario, Canada
Justin Keogh, Ph.D., Bond University, Robina, Queensland, Australia
Brad Love, Ph.D., Center for Health Communication, University of Texas, Austin, TX
Anja Mehnert, Ph.D., University Medical Center Leipzig, Leipzig, Germany
Larissa Nakhlyudov, MD, MPH, Harvard Medical School, Boston, MA
Paul Nathan MD, MSc, The Hospital for Sick Children, Toronto, ON
Katherine Smith, Ph.D.,Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD
Amye Tevaarwerk, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI
Xinhua Yu, MD, Ph.D., MSc, University of Memphis School of Public Health, Memphis, TN
Editorial Board
Tim A. Ahles, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY; Neil K. Aaronson, Ph.D., The Netherlands Cancer Institute, Amsterdam; Kathy B.Baumgartner, Ph.D., Health Sciences Center, University of Louisville, Louisville, KY; Joan Bloom, Ph.D., UC Berkley, Berkley, CA; Cathy J. Bradley, MPA, Ph.D.,Medical College of Virginia, Virginia Commonwealth University, Richmond, VA; Linda E. Carlson, Ph.D., University of Calgary, Calgary, AB, Canada; David Cella, Ph.D., Northwestern University, Feinberg School of Medicine,Chicago, IL; Victor T. Chang, MD, VA New Jersey Health Care System, East Orange, NJ; Jessica Chubak, Ph.D., Group Health Research Institute, Seattle, WA; Charles S. Cleeland, Ph.D., MD, Anderson Cancer Center, Houston, TX; Kerry S. Courneya, Ph.D., University of Alberta, Edmonton, Canada; Wendy Demark-Wahnefried, Ph.D., RD, University of Alabama at Birmingham, Birmingham, AL; Craig C. Earle, MD, MSc, Dana Farber Cancer Institute, Boston, MA; Karen M. Freund, MD, MPH, Boston University School of Medicine, Boston, MA; Patricia A. Ganz, MD, University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA; Marcia Grant, RN, DNSc, City of Hope Medical Center, Duarte, CA; Donna B. Greenberg, MD, Dana Farber Cancer Center, Boston, MA; Diana Greenfield, RN, Ph.D., Weston Park Hospital, Sheffield, UK; Melissa M. Hudson, MD, St. Jude Children’s Research Hospital, Memphis, TN; Linda A. Jacobs, Ph.D., RN, Ambramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Paul B. Jacobsen, Ph.D., H. Lee Moffitt Cancer Center, Tampa, FL; Gary L. Kreps, Ph.D., George Mason University, Fairfax,VA; Kate R. Lorig, RN, DrPH, Stanford University School of Medicine, Stanford, CA; Jeanne S. Mandelblatt, MD, MPH, Georgetown University School of Medicine, Washington, DC; Jun J. Mao, MD, MSCE, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA; Elizabeth Maunsell, Ph.D., Faculté de médecine, Université Laval, Quebec City, QC, Canada; Andrew H. Miller, MD, Emory University School of Medicine, Atlanta, GA; Kevin C. Oeffinger, MD; Duke University Medical Center, Durham, NC; Jamie S. Ostroff, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY; Jeffrey Peppercorn, MD, MPH, Harvard Medical School, Boston, MA; Gwendolyn P. Quinn, Ph.D., New York University, NY; Carolyn S. Rabin, Ph.D., William James College, Newton, MA; Leslie L. Robison, Ph.D., St. Jude Children’s Research Hospital, Memphis, TN; Julia H. Rowland, Ph.D., National Cancer Institute, National Institutes of Health, Bethesda, MD; Charles L. Shapiro, MD, Ohio State University Medical Center and Comprehensive Cancer Center, Columbus, OH; Pamela F. Short, Ph.D., Penn State University, University Park, PA; Annette L. Stanton, Ph.D., University of California Los Angeles, Los Angeles, CA; Karen L. Syrjala, Ph.D., Fred Hutchinson Cancer Research Center, Seattle, WA; Umberto Tirelli, MD, National Cancer Institute, Aviano, Italy; Peter C. Trask, Ph.D., MPH, Brown Medical School, Providence, RI; Jos H.Verbeek, MD, Amsterdam University, Amsterdam, The Netherlands; Diane Von Ah, Ph.D., RN, FAAN, Indiana University, School of Nursing, Indianapolis, IN; Edward H.Wagner, MD, MPH, MacColl Institute for Health Care Innovation, Group Health Cooperative, Seattle, WA; K. Robin Yabroff, Ph.D., Office of Health Policy, Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Bethesda, MD; Brad J. Zebrack, Ph.D., MSW, MPH, University of Michigan, Ann Arbor, MI